ReviewTranslational andrology and urology2026
Phosphodiesterase inhibitors for the management of lower urinary tract symptoms in men without benign prostatic hyperplasia: a systematic review.
Abdulaziz Bakhsh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.